title: [Spondyloarthritis including psoriatic arthritis].
authors.affiliation: Klinik für Innere Medizin, Abteilung Rheumatologie und Klinische Immunologie, Immanuel Krankenhaus Berlin.
authors.forename: A
authors.initials: A
authors.lastname: Krause
authors.affiliation: Klinik Innere Medizin IV (Rheumatologie, Klinische Immunologie, Nephrologie), HSK Dr. Horst Schmidt Klinik GmbH, Wiesbaden.
authors.forename: E
authors.initials: E
authors.lastname: Märker-Hermann
mesh_terms: D000068879:Adalimumab; D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use; D015535:Arthritis, Psoriatic / Q000175:diagnosis* / Q000188:drug therapy*; D000068582:Certolizumab Pegol; D015897:Comorbidity; D003299:Cooperative Behavior; D003937:Diagnosis, Differential; D000068800:Etanercept; D005858:Germany; D006073:Gout / Q000175:diagnosis / Q000188:drug therapy; D019983:Guideline Adherence; D015796:HLA-B27 Antigen / Q000032:analysis; D006801:Humans; D007140:Immunoglobulin Fab Fragments / Q000627:therapeutic use; D007074:Immunoglobulin G / Q000627:therapeutic use; D033183:Interdisciplinary Communication; D024821:Metabolic Syndrome / Q000175:diagnosis / Q000188:drug therapy; D011092:Polyethylene Glycols / Q000627:therapeutic use; D018124:Receptors, Tumor Necrosis Factor / Q000627:therapeutic use; D012017:Referral and Consultation; D058566:Sacroiliitis / Q000175:diagnosis / Q000188:drug therapy; D025242:Spondylarthropathies / Q000175:diagnosis* / Q000188:drug therapy*; D013167:Spondylitis, Ankylosing / Q000175:diagnosis* / Q000188:drug therapy; D013792:Thalidomide / Q000031:analogs & derivatives / Q000627:therapeutic use
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D015796:HLA-B27 Antigen; D007140:Immunoglobulin Fab Fragments; D007074:Immunoglobulin G; D018124:Receptors, Tumor Necrosis Factor; D011092:Polyethylene Glycols; D013792:Thalidomide; D000068879:Adalimumab; D000068800:Etanercept; D000068582:Certolizumab Pegol; C505730:apremilast